What companies are TNGX's competitors?

Tango Therapeutics, Inc. (TNGX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does TNGX compare to its peers?

The peer comparison table on this page shows Tango Therapeutics, Inc. (TNGX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does TNGX operate in?

Tango Therapeutics, Inc. (TNGX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

TNGX

Tango Therapeutics, Inc.

NASDAQ·Biotechnology · Healthcare

$22.23$0.66−2.88%

After hours·$22.27+0.18%

Market cap$3.75B·Market closed·Oct 28 4:00 PM EDT

Frequently Asked Questions About TNGX

What companies are TNGX's competitors?: Tango Therapeutics, Inc. (TNGX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does TNGX compare to its peers?: The peer comparison table on this page shows Tango Therapeutics, Inc. (TNGX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does TNGX operate in?: Tango Therapeutics, Inc. (TNGX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

TNGX

Tango Therapeutics, Inc.

NASDAQ·Biotechnology · Healthcare

$22.23$0.66−2.88%

After hours·$22.27+0.18%

Market cap$3.75B·Market closed·Oct 28 4:00 PM EDT

Peers

Sort:


RVMDRVMDRevolution Medicines, Inc.	Revolution Medicines, Inc.	$188.72	$40.4B
ERASERASErasca, Inc.	Erasca, Inc.	$15.12	$5.3B
RLAYRLAYRelay Therapeutics, Inc.	Relay Therapeutics, Inc.	$19.69	$4.3B
IDYAIDYAIDEAYA Biosciences, Inc.	IDEAYA Biosciences, Inc.	$33.96	$3.3B
NRIXNRIXNurix Therapeutics, Inc.	Nurix Therapeutics, Inc.	$27.26	$3.0B
NUVBNUVBNuvation Bio Inc.	Nuvation Bio Inc.	$4.59	$1.6B
CCCCCCCCC4 Therapeutics, Inc.	C4 Therapeutics, Inc.	$3.40	$417.7M
PRLDPRLDPrelude Therapeutics Incorporated	Prelude Therapeutics Incorporated	$4.14	$239.6M
FHTXFHTXFoghorn Therapeutics Inc.	Foghorn Therapeutics Inc.	$2.13	$126.5M
ACRVACRVAcrivon Therapeutics, Inc. Common Stock	Acrivon Therapeutics, Inc. Common Stock	$1.73	$74.1M

Frequently Asked Questions About TNGX

What companies are TNGX's competitors?: Tango Therapeutics, Inc. (TNGX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does TNGX compare to its peers?: The peer comparison table on this page shows Tango Therapeutics, Inc. (TNGX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does TNGX operate in?: Tango Therapeutics, Inc. (TNGX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.